Fourteen percent of LT recipients developed at least one CV event at a median of 2.5 (range: 0.005 – 7) yrs. An association was found between the Framingham score at LT and the development ACP-196 of CV events (p= .003 by Cox regression analysis). Moreover, an association was also found between the Framingham score and overall survival (p= .014 by Kaplan-Meier) with 1, 3 and 5 yrs survival rates of 89.5%, 87% and 82.5% in the low-risk group, 90%, 79% and 78% in the moderate risk group, and 74.5%, 67.5% and 61.5% in the high-risk group, respectively. Other variables associated with the development of CV events included age (p= .007), creatinine clearance (p= .020) and MMF use at discharge

(p=.011). By multivariate analysis, only creatinine clearance (HR: .98, 95/CI: .97-1.00; p= .009) and Framingham score (HR: 1.06, 95/CI: 1.02-1.10, p= .002) remained in the model. Conclusions: In our series, the Framingham score and renal function at LT were able to predict the development X-396 datasheet of post-LT CV events. Studies with higher number of CV events are needed to confirm these findings. Disclosures: Erica Villa – Advisory Committees or Review Panels: Abbvie, MSD, GSK; Grant/ Research Support: MSD, Roche Marina Berenguer – Advisory Committees or Review Panels: Novartis, Astellas, Janssen, BMS The following people have nothing to disclose: Tommaso Di Maira, Lorena Puchades, Angel Rubin, Carmen Vinaixa, María García Eliz, Fernando San Juan, Rafael Lóepez Andujar, Martin Prieto

Background: We aimed to assess potentially modifiable risk factors for poor 10-year liver transplant outcomes. We hypothesized that pre-transplant depression would be associated with decreased survival. Methods: Dehydratase After excluding patients transplanted for fulminant liver failure and with multi-organ transplants, all primary hepatic transplants at a single center between 2004-2014 were evaluated

in this retrospective cohort study. Factors associated with death were evaluated with Cox Proportional-hazards models. Acute rejection and graft failure were modeled using competing risk models, with death as a competing risk. Potential covariates included recipient demographics, donor age, MELD at transplant, etiology of liver disease, cold and warm ischemia time, and graft type including donation after cardiac death (DCD) vs. live-donor vs. standard grafts. Pre-transplant depression (per the transplant evaluation), substance use, and a Charlson Comorbidity Index were also assessed for all patients. Results: Liver transplant recipients (N=1095) were followed for a median of 4.6 years (IQR=1.8, 7.6). Of these, 313 experienced acute rejection, 66 required re-transplantation, and 347 died. The factors significantly associated with death in the final regression model included race (HR for African-American vs. Caucasian = 1.11 CI=1.01,1.21), depression pre-transplant (HR=1.58, CI=1.51,1.65), MELD (HR per point=1.02 CI=1.2,1.01), donor type (HR for cadaveric vs. live donor=2.